| scholarly article | Q13442814 |
| P50 | author | Anoop Haridass | Q60972024 |
| P2860 | cites work | SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial | Q57141292 |
| Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer | Q59587430 | ||
| Stage I nonsmall cell lung cancer in patients aged ≥75 years | Q59587510 | ||
| Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer | Q59587541 | ||
| Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma | Q59678030 | ||
| The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy | Q61771667 | ||
| Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients | Q71783537 | ||
| Radiation therapy alone for stage I non-small cell lung cancer | Q72569985 | ||
| Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects | Q72769997 | ||
| American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy | Q82710648 | ||
| Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy | Q84970348 | ||
| Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology | Q88825537 | ||
| Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC) | Q89005809 | ||
| Stereotactic body radiotherapy in the era of radiotherapy with immunotherapy | Q42344264 | ||
| Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer | Q43515284 | ||
| Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial | Q44375182 | ||
| Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy | Q45395100 | ||
| Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. | Q46484976 | ||
| Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). | Q47269792 | ||
| Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes | Q48631901 | ||
| Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose? | Q48661338 | ||
| Oligoprogressive Oncogene-addicted Lung Tumours: Does Stereotactic Body Radiotherapy Have a Role? Introducing the HALT Trial | Q49886544 | ||
| Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". | Q51100099 | ||
| Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung c | Q52582229 | ||
| Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. | Q53058203 | ||
| Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials. | Q53257268 | ||
| SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. | Q53781022 | ||
| Oligometastases. | Q55065168 | ||
| Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial | Q28709611 | ||
| Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis | Q30275557 | ||
| Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis | Q30303090 | ||
| Stereotactic body radiation therapy: the report of AAPM Task Group 101. | Q30451917 | ||
| Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly | Q30640824 | ||
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 | ||
| The stereotaxic method and radiosurgery of the brain. | Q33975919 | ||
| Stereotactic body radiotherapy for oligometastases. | Q34320125 | ||
| Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
| Actual 10-year survival after resection of colorectal liver metastases defines cure. | Q34699863 | ||
| A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy | Q35019637 | ||
| The role of radiotherapy in treatment of stage I non-small cell lung cancer | Q35162530 | ||
| Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis | Q35211240 | ||
| Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis | Q35263629 | ||
| Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer | Q36038600 | ||
| LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective | Q36235727 | ||
| Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer | Q36241457 | ||
| Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies | Q36446268 | ||
| Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer | Q36597088 | ||
| Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study | Q36866000 | ||
| Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial | Q37128114 | ||
| Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer | Q37420376 | ||
| The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage | Q37497743 | ||
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review | Q37884743 | ||
| International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery | Q38011485 | ||
| Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis | Q38021143 | ||
| Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases | Q38118440 | ||
| Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort | Q38152867 | ||
| A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | Q38790915 | ||
| Clinical results of cyberknife(r) radiosurgery for spinal metastases | Q39293118 | ||
| Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution | Q39308768 | ||
| Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy | Q40014973 | ||
| Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. | Q40307501 | ||
| Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort. | Q40423339 | ||
| Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy | Q40537887 | ||
| A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis. | Q40959732 | ||
| Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence | Q41706876 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 497 | |
| P577 | publication date | 2018-12-07 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Developments in Stereotactic Body Radiotherapy | |
| P478 | volume | 10 |
Search more.